New Technology to Streamline Drug Discovery
Amanda Haymond of @GeorgeMasonNews @GMU_COS explains a new discovery that includes protein painting technology and enables scientists to make discoveries in cancer research.
Related Articles
FDA Approves Lazcluze Rybrevant Combo in Advanced NSCLC: Data Revealed
FDA approves combination treatment for advanced non-small cell lung cancer (NSCLC) targeting specific EGFR mutations. Learn about the MARIPOSA trial results,…
FDA approves KEYTRUDA® / Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma SLIDES
FDA approved pembrolizumab (Keytruda) combined with chemotherapy for mesothelioma treatment. A new option for patients battling this aggressive disease.
SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer
FDA approves Kisqali for early high-risk breast cancer treatment. Learn about this new treatment option and its benefits for patients.
FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer ESMO 2024
Download Slides: https://oncologytube.com/slides-fda-approves-kisqali-ribociclib-for-early-high-risk-breast-cancer/The FDA has approved Kisqali (ribociclib) …
VIDEO: iTeos and GSK’s TIGIT Combination Therapy Shows Significant Promise at ESMO 2024
Promising results from the TIGIT combination therapy trial presented at ESMO 2024. Discover the potential of this treatment for lung cancer.
FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-L1 Cancer Immunotherapy in NSCLC
In this video, we explore the FDA approval of Genentech’s Tecentriq Hybreza, the first subcutaneous anti-PD-(L)1 immunotherapy for cancer. Approved on Septem…
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024: AVEO – OncologyTube
AVEO Oncology, a subsidiary of LG Chem, has announced the acceptance of its Phase 3 TiNivo-2 trial for a Proffered Paper oral presentation at the…
Breast Cancer Genetic Testing – Should Doctors Use ctDNA? Nathalie McDowell Johnson, MD
Dr. Nathalie M. Johnson, MD, discusses the importance of adopting ctDNA testing in breast cancer management. Find out how it can benefit patients with high-risk…
FDA Expands Endometrial Cancer Indication for Dostarlimab-gxly with Chemotherapy
Exciting news in endometrial cancer treatment: FDA approves dostarlimab-gxly for broader patient population. Learn about the clinical trial and its positive results.
90% Patients Unaware Of Simple Genetic Test for Cancer – Kevin Hughes, MD
Discover the problem of underutilization of genetic testing in cancer. Find out how it can lead to missed opportunities for early intervention.